Cartesian Therapeutics, Inc. announced On February 28, 2024, Aymeric Sallin, a member of the Board of Directors (the ?Board?) of the Company, notified the Company of his resignation from the Board, effective immediately, to pursue other opportunities. Prior to his resignation, Mr. Sallin served on the Board?s Compensation Committee, and in connection with his resignation, Mr. Sallin will cease service on such committee. Mr. Sallin?s resignation was not the result of a disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.2 USD | -9.85% | +5.14% | +12.20% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.20% | 413M | |
+10.44% | 107B | |
+0.82% | 106B | |
+6.72% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Cartesian Therapeutics, Inc. Announces Resignation of Aymeric Sallin as Member of the Board of Director and Member of Compensation Committee